U.S. Court of Appeals for the Federal Circuit, 2020

Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd

Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd
U.S. Court of Appeals for the Federal Circuit · Decided March 5, 2020

Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd

Opinion

Case: 18-2321 Document: 81 Page: 1 Filed: 03/05/2020

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ JANSSEN BIOTECH, INC., Plaintiff-Appellant v. CELLTRION HEALTHCARE CO., LTD., CELLTRION, INC., HOSPIRA, INC., Defendants-Cross-Appellants ______________________ 2018-2321, 2018-2350 ______________________ Appeals from the United States District Court for the District of Massachusetts in No. 1:17-cv-11008-MLW, Chief Judge Mark L. Wolf. ______________________ JUDGMENT ______________________ GREGORY DISKANT, Patterson Belknap Webb & Tyler LLP, New York, NY, argued for plaintiff-appellant. Also represented by ANDREW D. COHEN, ARON RUSSELL FISCHER, EUGENE M. GELERNTER.

JAMES F. HURST, Kirkland & Ellis LLP, Chicago, IL, ar- gued for defendants-cross-appellants. Also represented by BRYAN SCOTT HALES; WILLIAM H. BURGESS, JOHN C.

O'QUINN, Washington, DC.

Case: 18-2321 Document: 81 Page: 2 Filed: 03/05/2020

______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (WALLACH, TARANTO, and STOLL, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

March 5, 2020 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.